Date Topic
23/4/2010Freshfields elects nine to counsel role
29/3/2010Freshfields elects 18 in new generation of partners
18/3/2010Freshfields advises VEM on €3.6bn sale of Ratiopharm to Teva
15/3/2010Freshfields corporate partner relocates to Dubai
8/3/2010Freshfields announces association with The Law Firm of Salah Al-Hejailan in Saudi Arabia
12/11/2009Freshfields advises Advent on acquisition of Median in largest German buy-out deal to date
28/9/2009Freshfields advises Solvay on €5.2bn sale of pharmaceutical business
11/6/2009Litigation on the cards as firms look to sweat and protect IP assets during downturn
5/3/2009Freshfields advises Roche on record bond issuance
22/1/2009Freshfields advises Fresenius on $860m equivalent high yield bond issue
19/12/2008Freshfields advises Wyeth Pharmaceuticals on its acquisition of Thiakis Limited
9/5/2008Lord Darzi’s five pledges create the opportunity for increasing the pace of change but also risk creating increased costs for both the NHS and private sector providers, says Freshfields Bruckhaus Deringer
16/4/2008Roche announces acquisition of UK biotech company Piramed
5/9/2007Freshfields advises Morgan Stanley Real Estate on $1.1bn acquisition of Sunrise Senior Living
13/7/2007Freshfields advises Cinven on acquisition of USP Hospitales for €675m
19/6/2007Cinven reaches agreement to acquire BUPA's hospitals for £1.44bn
26/4/2007Freshfields advises AstraZeneca on acquisition of Medimmune
15/1/2007Kodak to sell Health Group to Onex for up to $2.55bn

News

Freshfields elects nine to counsel role View

Freshfields elects 18 in new generation of partners View

Briefings

Life sciences: China  View

Class actions in the EU: a threat to the life sciences industry?  View

Awards

Life Sciences Law Firm of the Year - FT/Mergermarket M&A Awards (2007)

View all awards

Contact